Oxford Biomedica Plc New (OXBDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 12-2021 | 12-2020 | 06-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -56,868 | 27,337 | -7,311 | -7,155 | -18,473 |
| Depreciation Amortization | 33,331 | 17,128 | 12,633 | 4,542 | 7,389 |
| Other Working Capital | 6,100 | -17,751 | -15,606 | -983 | -2,667 |
| Other Operating Activity | 1,834 | 8,289 | 14,285 | 2,432 | 9,272 |
| Operating Cash Flow | $-15,603 | $35,003 | $4,001 | $-1,164 | $-4,479 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 54,057 | -13,010 | -17,152 | -6,639 | -32,908 |
| Net Acquisitions | -122,708 | 0 | 0 | N/A | 0 |
| Other Investing Activity | -1,187 | 0 | 3,284 | 3,147 | 8,139 |
| Investing Cash Flow | $-69,838 | $-13,010 | $-13,868 | $-3,492 | $-24,769 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 121,986 | 63,539 | 49,030 | 47,313 | 8,817 |
| Financing Cash Flow | $121,986 | $63,539 | $49,030 | $47,313 | $8,817 |
| Exchange Rate Effect | 3,458 | 0 | 0 | N/A | 0 |
| Beginning Cash Position | 134,753 | 64,276 | 20,856 | 20,156 | 41,172 |
| End Cash Position | 174,755 | 149,809 | 60,018 | 62,813 | 20,741 |
| Net Cash Flow | $40,003 | $85,533 | $39,162 | $42,657 | $-20,432 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,603 | 35,003 | 4,001 | -1,164 | -4,479 |
| Free Cash Flow | -15,603 | 35,003 | 4,001 | -1,164 | -4,479 |